Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0445 Transporter Info | ||||
Gene Name | SLC6A13 | ||||
Transporter Name | Sodium- and chloride-dependent GABA transporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
ASCL1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A13 gene in hepatocellular carcinoma condition | [1] | ||||
TF Protein Name |
Achaete-scute homolog 1 | Transcription Factor Info | ||||
Studied Phenotype |
Hepatocellular carcinoma [ICD11: 2C12.02] | |||||
Tissue |
Liver | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human adult hepatocellular carcinoma cells (Huh7) | |||||
Detailed Description |
Achaete-scute homolog 1 (ASCL1) has been reported to activate the transcription of SLC6A13 gene in hepatocellular carcinoma condition, which leads to an increased expression of the drug transporter sodium- and chlorine-dependent GABA transporter 2. | |||||
Class1.3: Basic helix-span-helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
TFAP2A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A13 gene in health condition | [2] | ||||
TF Protein Name |
Transcription factor AP-2-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor AP-2-alpha (TFAP2A) has been reported to bind to the transcription of SLC6A13 gene in health condition, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
TFAP2C |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A13 gene | [3] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) can directly bind to the SLC6A13 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
Class2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
HNF4A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A13 gene in health condition | [4] | ||||
TF Protein Name |
Hepatocyte nuclear factor 4-alpha | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Hepatocyte nuclear factor 4-alpha (HNF4A) has been reported to bind to the transcription of SLC6A13 gene in health condition, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
NR2F2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A13 gene | [3] | ||||
TF Protein Name |
COUP transcription factor 2 | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
COUP transcription factor 2 (NR2F2) can directly bind to the SLC6A13 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
Class2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A13 gene | [5] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC6A13 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
Class2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 8 TF(s) Regulating This DT |
|||||
BCL6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A13 gene in health condition | [6] | ||||
TF Protein Name |
B-cell lymphoma 6 protein | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
B-cell lymphoma 6 protein (BCL6) has been reported to activate the transcription of SLC6A13 gene in health condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
CTCF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A13 gene | [3] | ||||
TF Protein Name |
Transcriptional repressor CTCF | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Cervix; Colon; Embryo; Epithelium; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional repressor CTCF (CTCF) can directly bind to the SLC6A13 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
KLF9 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A13 gene | [7] | ||||
TF Protein Name |
Krueppel-like factor 9 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Krueppel-like factor 9 (KLF9) can directly bind to the SLC6A13 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A13 gene | [8] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Liver; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC6A13 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
SALL4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A13 gene in health condition | [9] | ||||
TF Protein Name |
Sal-like protein 4 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Sal-like protein 4 (SALL4) has been reported to bind to the transcription of SLC6A13 gene in health condition, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
WT1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A13 gene in podocyte condition | [10] | ||||
TF Protein Name |
Wilms tumor protein | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Wilms tumor protein (WT1) has been reported to activate the transcription of SLC6A13 gene in podocyte condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
ZBTB7A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A13 gene | [7] | ||||
TF Protein Name |
Zinc finger and BTB domain-containing protein 7A | Transcription Factor Info | ||||
Tissue |
Uterus | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger and BTB domain-containing protein 7A (ZBTB7A) can directly bind to the SLC6A13 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
ZNF263 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A13 gene | [5] | ||||
TF Protein Name |
Zinc finger protein 263 | Transcription Factor Info | ||||
Tissue |
Kidney | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 263 (ZNF263) can directly bind to the SLC6A13 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
Class3.1: Homeo domain factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
HNF1B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A13 gene in renal cysts condition | [11] | ||||
TF Protein Name |
Hepatocyte nuclear factor 1-beta | Transcription Factor Info | ||||
Studied Phenotype |
Renal cysts [ICD11: GB80] | |||||
Tissue |
Kidney | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Zebrafish TgPT::EGFP) | |||||
Detailed Description |
Hepatocyte nuclear factor 1-beta (HNF1B) has been reported to activate the transcription of SLC6A13 gene in renal cysts condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
PBX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A13 gene in ovarian cancer condition | [12] | ||||
TF Protein Name |
Pre-B-cell leukemia transcription factor 1 | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Pre-B-cell leukemia transcription factor 1 (PBX1) has been reported to activate the transcription of SLC6A13 gene in ovarian cancer condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
Class3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 3 TF(s) Regulating This DT |
|||||
E2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A13 gene in MCF7 cells | [2] | ||||
TF Protein Name |
Transcription factor E2F1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Transcription factor E2F1 (E2F1) has been reported to bind to the transcription of SLC6A13 gene in MCF7 cells, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
E2F6 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A13 gene | [5] | ||||
TF Protein Name |
Transcription factor E2F6 | Transcription Factor Info | ||||
Tissue |
Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2F6 (E2F6) can directly bind to the SLC6A13 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
FOXA2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A13 gene | [8] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-beta | Transcription Factor Info | ||||
Tissue |
Embryo; Liver; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-beta (FOXA2) can directly bind to the SLC6A13 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
Class3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A13 gene in megakaryocytes condition | [13] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) has been reported to bind to the transcription of SLC6A13 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
SPI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A13 gene | [7] | ||||
TF Protein Name |
Transcription factor PU.1 | Transcription Factor Info | ||||
Tissue |
Blood; Brain; Embryo; Foreskin; Heart; Intestine; Kidney; Lung; Muscle; Penis; Renal cortex; Renal pelvis; Skin; Spinal cord; Stomach; Testes; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor PU.1 (SPI1) can directly bind to the SLC6A13 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
Class5.1: MADS box factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
SRF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Direct binding to SLC6A13 gene | [7] | ||||
TF Protein Name |
Serum response factor | Transcription Factor Info | ||||
Tissue |
Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Serum response factor (SRF) can directly bind to the SLC6A13 gene, which in turn affects the expression or function of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
Class6.4: Runt domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
RUNX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Binding to SLC6A13 gene in megakaryocytes condition | [13] | ||||
TF Protein Name |
Runt-related transcription factor 1 | Transcription Factor Info | ||||
Related DT Changes |
Direct regulating | |||||
Detailed Description |
Runt-related transcription factor 1 (RUNX1) has been reported to bind to the transcription of SLC6A13 gene in megakaryocytes condition, which leads to an affected expression of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
Class6.5: T-Box factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
EOMES |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon1 |
Activation of SLC6A13 gene in health condition | [14] | ||||
TF Protein Name |
Eomesodermin homolog | Transcription Factor Info | ||||
Studied Phenotype |
. | |||||
Related DT Changes |
Up regulating | |||||
Detailed Description |
Eomesodermin homolog (EOMES) has been reported to activate the transcription of SLC6A13 gene in health condition, which leads to an increased expression of the drug transporter Sodium- and chloride-dependent GABA transporter 2. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.